[Code of Federal Regulations]
[Title 38, Volume 1]
[Revised as of July 1, 2004]
From the U.S. Government Printing Office via GPO Access
[CITE: 38CFR4.115b]

[Page 429-432]
 
            TITLE 38--PENSIONS, BONUSES, AND VETERANS' RELIEF
 
                CHAPTER I--DEPARTMENT OF VETERANS AFFAIRS
 
PART 4_SCHEDULE FOR RATING DISABILITIES--Table of Contents
 
                      Subpart B_Disability Ratings
 
Sec. 4.115b  Ratings of the genitourinary system--diagnoses.

------------------------------------------------------------------------
                                                                  Rating
------------------------------------------------------------------------
      Note: When evaluating any claim involving loss or loss of
       use of one or more creative organs, refer to Sec. 3.350
       of this chapter to determine whether the veteran may be
       entitled to special monthly compensation. Footnotes in
       the schedule indicate conditions which potentially
       establish entitlement to special monthly compensation;
       however, there are other conditions in this section which
       under certain circumstances also establish entitlement to
       special monthly compensation.

7500 Kidney, removal of one:
      Minimum evaluation........................................      30
      Or rate as renal dysfunction if there is nephritis,
       infection, or pathology of the other.
7501 Kidney, abscess of:
      Rate as urinary tract infection...........................  ......

[[Page 430]]


7502 Nephritis, chronic:
      Rate as renal dysfunction.
7504 Pyelonephritis, chronic:
      Rate as renal dysfunction or urinary tract infection,
       whichever is predominant.
7505 Kidney, tuberculosis of:
      Rate in accordance with Sec. Sec. 4.88b or 4.89,
       whichever is appropriate.
7507 Nephrosclerosis, arteriolar:
      Rate according to predominant symptoms as renal
       dysfunction, hypertension or heart disease. If rated
       under the cardiovascular schedule, however, the
       percentage rating which would otherwise be assigned will
       be elevated to the next higher evaluation.
7508 Nephrolithiasis:
      Rate as hydronephrosis, except for recurrent stone
       formation requiring one or more of the following:
        1. diet therapy
        2. drug therapy
        3. invasive or non-invasive procedures more than two          30
         times/year.............................................
7509 Hydronephrosis:
      Severe; Rate as renal dysfunction.
    Frequent attacks of colic with infection (pyonephrosis),          30
     kidney function impaired...................................
    Frequent attacks of colic, requiring catheter drainage......      20
    Only an occasional attack of colic, not infected and not          10
     requiring catheter drainage................................
7510 Ureterolithiasis:
      Rate as hydronephrosis, except for recurrent stone
       formation requiring one or more of the following:
        1. diet therapy
        2. drug therapy
        3. invasive or non-invasive procedures more than two          30
         times/year.............................................
7511 Ureter, stricture of:
      Rate as hydronephrosis, except for recurrent stone
       formation requiring one or more of the following:
        1. diet therapy
        2. drug therapy
        3. invasive or non-invasive procedures more than two          30
         times/year.............................................
7512 Cystitis, chronic, includes interstitial and all
 etiologies, infectious and non-infectious:
      Rate as voiding dysfunction.
7515 Bladder, calculus in, with symptoms interfering with
 function:
      Rate as voiding dysfunction
7516 Bladder, fistula of:
      Rate as voiding dysfunction or urinary tract infection,
       whichever is predominant.
      Postoperative, suprapubic cystotomy.......................     100
7517 Bladder, injury of:
      Rate as voiding dysfunction.
7518 Urethra, stricture of:
      Rate as voiding dysfunction.
7519 Urethra, fistual of:
      Rate as voiding dysfunction.
      Multiple urethroperineal fistulae.........................     100
7520 Penis, removal of half or more.............................      30
      Or rate as voiding dysfunction.
7521 Penis removal of glans.....................................      20
      Or rate as voiding dysfunction.
7522 Penis, deformity, with loss of erectile power--20 \1\......
7523 Testis, atrophy complete:..................................
      Both--20 \1\
      One--0 \1\
7524 Testis, removal:...........................................
      Both--30 \1\
      One--0 \1\

      Note: In cases of the removal of one testis as the result
       of a service-incurred injury or disease, other than an
       undescended or congenitally undeveloped testis, with the
       absence or nonfunctioning of the other testis unrelated
       to service, an evaluation of 30 percent will be assigned
       for the service-connected testicular loss. Testis,
       underscended, or congenitally undeveloped is not a
       ratable disability.

7525 Epididymo-orchitis, chronic only:
      Rate as urinary tract infection.
      For tubercular infections: Rate in accordance with Sec.
       Sec. 4.88b or 4.89, whichever is appropriate.
7527 Prostate gland injuries, infections, hypertrophy,
 postoperative residuals:
      Rate as voiding dysfunction or urinary tract infection,
       whichever is predominant.
7528 Malignant neoplasms of the genitourinary system............     100

[[Page 431]]


      Note--Following the cessation of surgical, X-ray,
       antineoplastic chemotherapy or other therapeutic
       procedure, the rating of 100 percent shall continue with
       a mandatory VA examination at the expiration of six
       months. Any change in evaluation based upon that or any
       subsequent examination shall be subject to the provisions
       of Sec. 3.105(e) of this chapter. If there has been no
       local reoccurrence or metastasis, rate on residuals as
       voiding dysfunction or renal dysfunction, whichever is
       predominant.
7529 Benign neoplasms of the genitourinary system:
      Rate as voiding dysfunction or renal dysfunction,
       whichever is predominant.
7530 Chronic renal disease requiring regular dialysis:
      Rate as renal dysfunction.
7531 Kidney transplant:
      Following transplant surgery..............................     100
      Thereafter: Rate on residuals as renal dysfunction,             30
       minimum rating...........................................
      Note--The 100 percent evaluation shall be assigned as of
       the date of hospital admission for transplant surgery and
       shall continue with a mandatory VA examination one year
       following hospital discharge. Any change in evaluation
       based upon that or any subsequent examination shall be
       subject to the provisions of Sec. 3.105(e) of this
       chapter.
7532 Renal tubular disorders (such as renal glycosurias,
 aminoacidurias, renal tubular acidosis, Fanconi's syndrome,
 Bartter's syndrome, related disorders of Henle's loop and
 proximal or distal nephron function, etc.):
      Minimum rating for symptomatic condition..................      20
      Or rate as renal dysfunction.
7533 Cystic diseases of the kidneys (polycystic disease, uremic
 medullary cystic disease, Medullary sponge kidney, and similar
 conditions):
      Rate as renal dysfunction.
7534 Atherosclerotic renal disease (renal artery stenosis or
 atheroembolic renal disease):
      Rate as renal dysfunction.
7535 Toxic nephropathy (antibotics, radiocontrast agents,
 nonsteroidal anti-inflammatory agents, heavy metals, and
 similar agents):
      Rate as renal dysfunction.
7536 Glomerulonephritis:
      Rate as renal dysfunction.
7537 Interstitial nephritis:
      Rate as renal dysfunction.
7538 Papillary necrosis:
      Rate as renal dysfunction.
7539 Renal amyloid disease:
      Rate as renal dysfunction.
7540 Disseminated intravascular coagulation with renal cortical
 necrosis:
      Rate as renal dysfunction.
7541 Renal involvement in diabetes mellitus, sickle cell anemia,
 systemic lupus erythematosus, vasculitis, or other systemic
 disease processes.
      Rate as renal dysfunction.
7542 Neurogenic bladder:
      Rate as voiding dysfunction.
------------------------------------------------------------------------
\1\ Review for entitlement to special monthly compensation under Sec.
  3.350 of this chapter.


[59 FR 2527, Jan. 18, 1994; 59 FR 14567, Mar. 29, 1994, as amended at 59 
FR 46339, Sept. 8, 1994]

[[Page 432]]

          Gynecological Conditions and Disorders of the Breast